Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.64 USD | +0.36% | +9.91% | +137.59% |
09:26am | Dyne Therapeutics Insider Sold Shares Worth $1,002,751, According to a Recent SEC Filing | MT |
May. 22 | Dyne Therapeutics Prices $325.5 Million Common Stock Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+137.59% | 3.09B | |
+64.10% | 62.59B | |
-1.18% | 41.18B | |
+44.76% | 40.29B | |
-8.29% | 27.9B | |
+13.27% | 26.21B | |
-21.52% | 19.09B | |
+5.51% | 13.08B | |
+25.07% | 12.26B | |
+28.39% | 12.05B |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- Dyne Therapeutics Gets FDA Orphan Drug, Rare Pediatric Labels for Duchenne Muscular Dystrophy Treatment